SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-06-013527
Filing Date
2006-11-06
Accepted
2006-11-06 08:08:13
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y26593e10vq.htm 10-Q 448295
2 EX-10.1: LICENSE AND COLLABORATION AGREEMENT y26593exv10w1.htm EX-10.1 492142
3 EX-12.1: STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGE y26593exv12w1.htm EX-12.1 19924
4 EX-31.1: CERTIFICATION y26593exv31w1.htm EX-31.1 8538
5 EX-31.2: CERTIFICATION y26593exv31w2.htm EX-31.2 8872
6 EX-32: CERTIFICATION y26593exv32.htm EX-32 3394
  Complete submission text file 0000950123-06-013527.txt   982468
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 061188694
SIC: 2834 Pharmaceutical Preparations